Review Article Online Published: 16 Oct 2024 | ||||||||||||
The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis Atheer Alshutayli, Essa Alsultan, Muath Alshammari, Faisal Alqahtani, Tuqa Alharbi, Fatimah Alnaim, Seham Alshalahi, Dhai Almuteri, Mohammed Albarqi.
|
How to Cite this Article |
Pubmed Style Alshutayli A, Alsultan E, Alshammari M, Alqahtani F, Alharbi T, Alnaim F, Alshalahi S, Almuteri D, Albarqi M. The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis. IJMDC. Online First: 16 Oct, 2024. doi:10.24911/IJMDC.51-1725216272 Web Style Alshutayli A, Alsultan E, Alshammari M, Alqahtani F, Alharbi T, Alnaim F, Alshalahi S, Almuteri D, Albarqi M. The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis. https://www.ijmdc.com/?mno=218242 [Access: November 27, 2024]. doi:10.24911/IJMDC.51-1725216272 AMA (American Medical Association) Style Alshutayli A, Alsultan E, Alshammari M, Alqahtani F, Alharbi T, Alnaim F, Alshalahi S, Almuteri D, Albarqi M. The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis. IJMDC. Online First: 16 Oct, 2024. doi:10.24911/IJMDC.51-1725216272 Vancouver/ICMJE Style Alshutayli A, Alsultan E, Alshammari M, Alqahtani F, Alharbi T, Alnaim F, Alshalahi S, Almuteri D, Albarqi M. The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis. IJMDC, [cited November 27, 2024]; Online First: 16 Oct, 2024. doi:10.24911/IJMDC.51-1725216272 Harvard Style Alshutayli, A., Alsultan, . E., Alshammari, . M., Alqahtani, . F., Alharbi, . T., Alnaim, . F., Alshalahi, . S., Almuteri, . D. & Albarqi, . M. (2024) The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis. IJMDC, Online First: 16 Oct, 2024. doi:10.24911/IJMDC.51-1725216272 Turabian Style Alshutayli, Atheer, Essa Alsultan, Muath Alshammari, Faisal Alqahtani, Tuqa Alharbi, Fatimah Alnaim, Seham Alshalahi, Dhai Almuteri, and Mohammed Albarqi. 2024. The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis. International Journal of Medicine in Developing Countries, Online First: 16 Oct, 2024. doi:10.24911/IJMDC.51-1725216272 Chicago Style Alshutayli, Atheer, Essa Alsultan, Muath Alshammari, Faisal Alqahtani, Tuqa Alharbi, Fatimah Alnaim, Seham Alshalahi, Dhai Almuteri, and Mohammed Albarqi. "The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis." International Journal of Medicine in Developing Countries Online First: 16 Oct, 2024. doi:10.24911/IJMDC.51-1725216272 MLA (The Modern Language Association) Style Alshutayli, Atheer, Essa Alsultan, Muath Alshammari, Faisal Alqahtani, Tuqa Alharbi, Fatimah Alnaim, Seham Alshalahi, Dhai Almuteri, and Mohammed Albarqi. "The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis." International Journal of Medicine in Developing Countries Online First: 16 Oct, 2024. Web. 27 Nov 2024 doi:10.24911/IJMDC.51-1725216272 APA (American Psychological Association) Style Alshutayli, A., Alsultan, . E., Alshammari, . M., Alqahtani, . F., Alharbi, . T., Alnaim, . F., Alshalahi, . S., Almuteri, . D. & Albarqi, . M. (2024) The effect of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptor agonists in nonalcoholic fatty liver disease in type 2 diabetic patients: a systematic review and meta-analysis. International Journal of Medicine in Developing Countries, Online First: 16 Oct, 2024. doi:10.24911/IJMDC.51-1725216272 |